Solasia Pharma KK (TSE:4597) Cyclically Adjusted FCF per Share: 円-16.93 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4597 Solasia Pharma KK TSE:4597
49 GF Score
Price 円26.00
GF Value 円2.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Solasia Pharma KK Cyclically Adjusted FCF per Share?

Solasia Pharma KK TSE:4597 -3.70% 49 Cyclically Adjusted FCF per Share is 円-16.93 as of Mar. 2026. GuruFocus rates TSE:4597 with a GF Score™ of 49/100 and a GF Value™ of 円2.41 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Solasia Pharma KK's adjusted free cash flow per share for the three months ended in Mar. 2026 was 円-0.235. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円-16.93 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-20), Solasia Pharma KK's current stock price is 円26.00. Solasia Pharma KK's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was 円-16.93. Solasia Pharma KK's Cyclically Adjusted Price-to-FCF of today is .


Solasia Pharma KK  (TSE:4597) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Solasia Pharma KK Cyclically Adjusted FCF per Share Related Terms


Solasia Pharma KK Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK Cyclically Adjusted FCF per Share Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Solasia Pharma KK Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.49 -17.22 0.00 0.00 -16.93

TSE:4597 vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solasia Pharma KK Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Solasia Pharma KK's Cyclically Adjusted Price-to-FCF falls into.


TSE:4597
49GF Score
Solasia Pharma KK TSE:4597
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Solasia Pharma KK's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.235/112.7000*112.7000
=-0.235

Current CPI (Mar. 2026) = 112.7000.

Solasia Pharma KK Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -1.160 97.900 -1.335
201606 -6.458 98.100 -7.419
201609 -5.407 98.000 -6.218
201612 0.857 98.400 0.982
201703 -4.853 98.100 -5.575
201706 -4.932 98.500 -5.643
201709 -1.626 98.800 -1.855
201712 -5.805 99.400 -6.582
201803 -6.815 99.200 -7.742
201806 -8.032 99.200 -9.125
201809 -7.811 99.900 -8.812
201812 -5.285 99.700 -5.974
201903 -12.107 99.700 -13.686
201906 -1.989 99.800 -2.246
201909 -5.469 100.100 -6.157
201912 4.661 100.500 5.227
202003 -6.477 100.300 -7.278
202006 -8.177 99.900 -9.225
202009 -5.991 99.900 -6.759
202012 -4.627 99.300 -5.251
202103 -5.179 99.900 -5.843
202106 -4.406 99.500 -4.991
202109 -7.094 100.100 -7.987
202112 -3.602 100.100 -4.055
202203 -4.291 101.100 -4.783
202206 -2.739 101.800 -3.032
202209 -3.280 103.100 -3.585
202212 -5.820 104.100 -6.301
202303 1.328 104.400 1.434
202306 -3.292 105.200 -3.527
202309 0.404 106.200 0.429
202312 -0.576 106.800 -0.608
202403 -0.942 107.200 -0.990
202406 -1.623 108.200 -1.691
202412 0.000 110.700 0.000
202503 0.968 111.100 0.982
202506 -1.110 111.700 -1.120
202509 0.000 112.000 0.000
202512 0.000 113.000 0.000
202603 -0.235 112.700 -0.235

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of 円-16.93 mean?
Solasia Pharma KK (TSE:4597) has a Cyclically Adjusted FCF per Share of 円-16.93 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Cyclically Adjusted FCF per Share too high?
Solasia Pharma KK's current Cyclically Adjusted FCF per Share is 円-16.93. Overall, Solasia Pharma KK has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Solasia Pharma KK's Cyclically Adjusted FCF per Share of 円-16.93 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Solasia Pharma KK and its competitors. Solasia Pharma KK's current Cyclically Adjusted FCF per Share is 円-16.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Significantly Overvalued. The stock's GF Value™ is 円2.41, compared to a current price of 円26.00 — trading 978.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is 円-16.93. Solasia Pharma KK's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Cyclically Adjusted FCF per Share is 円-16.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be overvalued. The current stock price of 円26.00 is trading 978.8% above its estimated GF Value™ of 円2.41. GuruFocus considers Solasia Pharma KK to be Significantly Overvalued.

Key valuation signals for TSE:4597:

  • Cyclically Adjusted FCF per Share: 円-16.93
  • GF Value™: 円2.41 vs. price of 円26.00 (978.8% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Solasia Pharma KK Business Description

Other Exchanges 9SO:Germany
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
49GF Score

Get the complete analysis for TSE:4597

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円26.00
Price
円2.41
GF Value